Black Rock Inc. Landec Corp \Ca\ Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Black Rock Inc. holds 1,452,634 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,452,634

Previous 478,816 203.38%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	N/A	973,818 Added 203.38%	1,452,634 $0
Q1 2024 May 10, 2024	SELL	N/A	-120,484 Reduced 20.1%	478,816 $0
Q4 2023 Feb 13, 2024	BUY	N/A	87,873 Added 17.18%	599,300 $0
Q3 2023 Nov 13, 2023	SELL	N/A	-20,616 Reduced 3.87%	511,427 $0
Q2 2023 Aug 11, 2023	SELL	N/A	-1,366,452 Reduced 71.98%	532,043 $0
Q1 2023 May 12, 2023	BUY	N/A	50,342 Added 2.72%	1,898,495 $0
Q4 2022 Feb 13, 2023	BUY	$0.0 - $9.95 $0 - $407,024	40,907 Added 2.26%	1,848,153 $0
Q3 2022 Nov 14, 2022	SELL	$8.57 - $11.57 $812,230 - $1.1 Million	-94,776 Reduced 4.98%	1,807,246 $16.1 Million
Q2 2022 Aug 12, 2022	BUY	$8.84 - $11.64 $82,600 - $108,764	9,344 Added 0.49%	1,902,022 $19 Million
Q1 2022 May 12, 2022	SELL	$10.07 - $11.93 $541,564 - $641,595	-53,780 Reduced 2.76%	1,892,678 $21.9 Million
Q4 2021 Feb 10, 2022	SELL	$7.95 - $11.24 $1.32 Million - $1.86 Million	-165,724 Reduced 7.85%	1,946,458 $21.6 Million
Q3 2021 Nov 09, 2021	SELL	$9.22 - $12.44 $859,552 - $1.16 Million	-93,227 Reduced 4.23%	2,112,182 $19.5 Million
Q2 2021 Aug 11, 2021	BUY	$9.91 - $12.78 $21.9 Million - $28.2 Million	2,205,409 New	2,205,409 $24.8 Million

Others Institutions Holding LNDC

# of Institutions

Shares Held

20.5M

Call Options Held

65.8K

Put Options Held

14.1K

View Full List

About LANDEC CORP \CA\

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

More about LNDC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account